In mouse syngeneic rhabdomyosarcoma models, tumors from a rhabdomyosarcoma cell line expressing high MHC I (M3-9-M) responded to HSV1716 and anti-PD-1, whereas tumors with MHC I low (76–9) did not respond [62]. The gene discussed is PDCD1; the disease is rhabdomyosarcoma.